Oncology Information System Market Overview
The Oncology Information System Market is expanding as healthcare providers increasingly adopt digital technologies to improve cancer treatment planning, patient management, clinical workflows, and oncology data management. The growing incidence of cancer, demand for personalized treatment, and increasing integration of artificial intelligence, machine learning, and advanced analytics are strengthening the need for specialized information systems across oncology care.
According to the report published in August 2026, the global Oncology Information System Market was valued at USD 4.17 billion in 2024 and USD 4.52 billion in 2025. The market is projected to reach USD 10 billion by 2035, registering a CAGR of 8.3% during the 2026–2035 forecast period. North America remains the leading regional market, valued at USD 2.12 billion in 2024 and projected to reach USD 4.5 billion by 2035. The Treatment Planning segment was valued at USD 1.058 billion in 2024 and is expected to reach USD 2.909 billion by 2035.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.wiseguyreports.com/reports/oncology-information-system-market
Key Players:
Philips Healthcare, Accuray, Dilon Technologies, Mevion Medical Systems, Elekta, Mirada Medical, Brainlab, ViewRay, Innovative Imaging Technologies, RaySearch Laboratories, Varian Medical Systems, CIVCO Medical Solutions, Siemens Healthineers, GE Healthcare, and Carestream Health are among the key companies profiled in the global Oncology Information System Market.
The growth of the Oncology Information System Market is being driven by the rising incidence of cancer and the growing requirement for efficient systems capable of managing complex patient and treatment information. Healthcare organizations are increasingly looking for solutions that integrate clinical data, treatment planning, electronic health records, and patient-management functions. Technological advancements in artificial intelligence and machine learning are also enabling predictive analytics, treatment personalization, and improved clinical decision-making. Growing investment in cancer research and the continued digitization of healthcare are further supporting market expansion.
Market segmentation covers Application, Deployment, End User, Component, and Region. By application, the market includes Treatment Planning, Clinical Workflow Management, Patient Management, and Data Management. Treatment Planning represents a major application, with its value projected to increase from USD 1.058 billion in 2024 to USD 2.909 billion by 2035. By deployment, the market is divided into On-Premise, Cloud-Based, and Web-Based solutions. End users include Hospitals, Ambulatory Surgical Centers, and Research Institutes, while components comprise Software, Services, and Hardware.
The market also presents opportunities through AI-driven treatment optimization, personalized medicine, genomic data integration, telehealth, and enhanced interoperability. Healthcare organizations can benefit from systems capable of connecting information across multiple platforms and providing clinicians with comprehensive patient insights. Cloud-based solutions are also creating opportunities through greater scalability and flexibility, while real-time data integration can support more coordinated and efficient oncology care.
Recent Developments and Market Trends:
1. Increasing Integration of Artificial Intelligence:
Artificial intelligence and machine learning are becoming increasingly important within oncology information systems. These technologies can support predictive analytics, treatment personalization, and clinical decision-making while helping healthcare providers manage increasingly complex cancer-care data.
2. Growing Adoption of Cloud-Based Solutions:
Cloud-based oncology information systems are gaining attention because of their scalability, flexibility, and ability to reduce infrastructure requirements. They can also facilitate access to oncology information across healthcare settings and support collaboration among clinical teams.
3. Greater Emphasis on Data Interoperability:
Healthcare providers are placing increasing emphasis on interoperability as oncology care involves information from imaging, laboratory systems, treatment platforms, and electronic health records. Integrated systems can help clinicians access more complete patient information and improve care coordination.
4. Expansion of Personalized Cancer Care:
The increasing focus on personalized medicine is creating demand for information systems capable of integrating patient-specific clinical and genomic information. Such capabilities can help healthcare professionals develop more individualized treatment strategies and monitor outcomes.
5. Recent Industry Partnerships and Technology Development:
Recent developments include a strategic partnership announced by Siemens Healthineers and Elekta in March 2025 to create an integrated oncology information system platform. Brainlab also launched a cloud-based oncology information system module in January 2025, while RaySearch Laboratories announced a major US cancer-center contract in December 2024 involving integration with an oncology information system.
Reasons to Buy the Report:
- Comprehensive Market Assessment: The report provides historical market information and forecasts covering the 2020–2024 historical period and projections through 2035.
- Detailed Segmentation Analysis: The study evaluates the market across application, deployment, end user, component, and regional categories.
- Regional Growth Insights: The report provides detailed assessments of North America, Europe, Asia Pacific, South America, and the Middle East and Africa, with North America maintaining the leading position.
- Competitive Landscape: The study profiles major companies operating in oncology information systems and examines technological developments and competitive positioning.
- Growth Opportunity Identification: The report highlights opportunities linked to AI integration, personalized medicine, telehealth, genomic data, interoperability, and patient engagement.
Future Outlook:
The Oncology Information System Market is expected to maintain steady expansion through 2035, growing from USD 4.52 billion in 2025 to USD 10 billion by 2035 at a CAGR of 8.3%. North America is expected to remain the dominant regional market, with its value projected to increase from USD 2.12 billion in 2024 to USD 4.5 billion by 2035. Treatment Planning is expected to remain a significant application, reaching USD 2.909 billion by 2035. Continued adoption of AI, cloud-based technologies, personalized medicine, interoperable healthcare platforms, and advanced oncology data-management solutions is expected to shape the market’s long-term development.
➤➤Explore Our Latest Related Reports:
